621 - ¿EXISTEN DIFERENCIAS ENTRE LA ENDOCARDITIS INFECCIOSA SOBRE VÁLVULA PROTÉSICA AÓRTICA BIOLÓGICA QUIRÚRGICA Y PERCUTÁNEA (TAVI)?
Adriana Hernández Belmonte(Hospital Universitario del Vinalopó), María Sánchez Ledesma(Complejo Hospitalario de Salamanca), Onán Pérez Hernández, Azucena Rodríguez-Guardado, Arturo Artero Mora, Javier de la Fuente Aguado(Povisa Hospital), Fátima Boumhir Lendínez, David Puertas Miranda, Carlos Bea Serrano, Juan Cantón de Seoane, María de los Ángeles Tejero Delgado, Josep Cucurull Canosa
Cited by 0
Related Papers
Crimean-Congo Hemorrhagic Fever, Spain, 2013–2021
|Emerging infectious diseases|2023|81
Predicting Success and Long-Term Outcomes of Percutaneous Mitral Valvuloplasty: A Multifactorial Score
|The American Journal of Medicine|2009|52
Identification of serum endoglin as a novel prognostic marker after acute myocardial infarction
|Journal of Cellular and Molecular Medicine|2008|51
Association between -T786C NOS3 polymorphism and resistant hypertension: a prospective cohort study
|BMC Cardiovascular Disorders|2009|34
Impact of Pre- and Postprocedural Mitral Regurgitation on Outcomes After Percutaneous Mitral Valvuloplasty for Mitral Stenosis
|The American Journal of Cardiology|2009|33